Because of qualitative methods used in these studies, connection between CK1-mediated tau phosphorylation identified by MS analysis or immunological methods and the role of CK1 in AD by determining the effect of CK1-mediated phosphorylation on tau aggregation has remained elusive. The gene discussed is MAPT; the disease is Alzheimer disease.